Tumor heterogeneity
We study how diversity within tumors influences progression, adaptation, and response to therapy.
Cancer ecology · evolution · therapy
The CancerEvo Group combines mathematical modeling with experimental cancer biology to understand treatment resistance and help design more durable therapies.
What we investigate
Tumors are heterogeneous populations under selection. Treatment changes that selection—and the evolutionary paths available to cancer cells.
We study how diversity within tumors influences progression, adaptation, and response to therapy.
We model how cancer cell populations respond to treatment and to their ecological context.
We seek evolution-informed strategies that anticipate resistance rather than only reacting to it.
Our approach
Models become most useful when they are developed in close dialogue with experiments and clinically meaningful questions.